- Home
- ABLV vs MYO Comparison
ABLV vs MYO Comparison
Compare ABLV & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- MYO
- Stock Information
- Founded
- ABLV 2015
- MYO 2004
- Country
- ABLV China
- MYO United States
- Employees
- ABLV N/A
- MYO N/A
- Industry
- ABLV
- MYO Industrial Specialties
- Sector
- ABLV
- MYO Health Care
- Exchange
- ABLV Nasdaq
- MYO Nasdaq
- Market Cap
- ABLV 32.9M
- MYO 33.2M
- IPO Year
- ABLV N/A
- MYO 2017
- Fundamental
- Price
- ABLV $0.65
- MYO $0.89
- Analyst Decision
- ABLV
- MYO Strong Buy
- Analyst Count
- ABLV 0
- MYO 3
- Target Price
- ABLV N/A
- MYO $7.67
- AVG Volume (30 Days)
- ABLV 9.4K
- MYO 801.8K
- Earning Date
- ABLV 12-19-2025
- MYO 11-10-2025
- Dividend Yield
- ABLV N/A
- MYO N/A
- EPS Growth
- ABLV N/A
- MYO N/A
- EPS
- ABLV 0.05
- MYO N/A
- Revenue
- ABLV $114,319,869.00
- MYO $41,643,203.00
- Revenue This Year
- ABLV N/A
- MYO $24.69
- Revenue Next Year
- ABLV N/A
- MYO $20.91
- P/E Ratio
- ABLV $14.37
- MYO N/A
- Revenue Growth
- ABLV N/A
- MYO 65.00
- 52 Week Low
- ABLV $0.55
- MYO $0.71
- 52 Week High
- ABLV $1.77
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- ABLV 39.23
- MYO 52.08
- Support Level
- ABLV $0.61
- MYO $0.71
- Resistance Level
- ABLV $0.70
- MYO $0.88
- Average True Range (ATR)
- ABLV 0.06
- MYO 0.07
- MACD
- ABLV -0.00
- MYO 0.02
- Stochastic Oscillator
- ABLV 33.16
- MYO 69.00
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).